Development of Human Monoclonal Antibody for Claudin-3 Overexpressing Carcinoma Targeting
Sign Up to like & getrecommendations! Published in 2019 at "Biomolecules"
DOI: 10.3390/biom10010051
Abstract: Most malignant tumors originate from epithelial tissues in which tight junctions mediate cell–cell interactions. Tight junction proteins, especially claudin-3 (CLDN3), are overexpressed in various cancers. Claudin-3 is exposed externally during tumorigenesis making it a potential… read more here.
Keywords: development human; cldn3; carcinoma; monoclonal antibody ... See more keywords